<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02390011</url>
  </required_header>
  <id_info>
    <org_study_id>149516</org_study_id>
    <nct_id>NCT02390011</nct_id>
  </id_info>
  <brief_title>Pilot Study of Coil Arrays in Patients With Advanced Solid Tumor Malignancies</brief_title>
  <official_title>A Pilot Study of Novel Magnetic Resonance Coil Arrays to Improve the Characterization of Liver Metastases in Patients With Advanced Solid Tumor Malignancies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single center pilot study testing the use of novel coil arrays with MR liver
      imaging. In part A of the study, up to 30 healthy volunteers will be scanned, with iterative
      adjustment of coil array geometry and design to optimize imaging characterstics. In Part B of
      the study, 40 patients with advanced solid tumors and at least one liver metastasis measuring
      &gt; 1.5 cm in diameter on standard anatomic scans will undergo MR liver imaging with the newly
      designed coil array, with the use of gadolinium contrast. Patients with liver tumors will
      have the option of undergoing a second MR liver scan during the course of subsequent systemic
      therapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 8, 2015</start_date>
  <completion_date type="Actual">May 16, 2015</completion_date>
  <primary_completion_date type="Actual">May 16, 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Spatial Resolution</measure>
    <time_frame>Day 1</time_frame>
    <description>Adjust the coil array to optimize spatial resolution in healthy volunteers</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Scan coverage</measure>
    <time_frame>Day 1</time_frame>
    <description>Adjust the coil array to optimize scan coverage of the liver in healthy volunteers</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean contrast-to-noise ratio</measure>
    <time_frame>Day 1</time_frame>
    <description>Detectable using the coil array</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Minimum size of detectable metastatic lesion</measure>
    <time_frame>Day 1</time_frame>
    <description>Detected by MRI scan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree signal</measure>
    <time_frame>Day 1</time_frame>
    <description>Detected by gandolinium contrast in MRI scan within liver metastases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time-to-peak signal</measure>
    <time_frame>Day 1</time_frame>
    <description>Detected by gandolinium contrast in MRI scan within liver metastases</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">7</enrollment>
  <condition>Neoplams</condition>
  <arm_group>
    <arm_group_label>MRI</arm_group_label>
    <description>Day 1</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MRI</intervention_name>
    <arm_group_label>MRI</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Advanced Solid Tumor Malignancies
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria (Part B only - Patients with advanced solid tumor):

          -  Advanced solid tumor malignancy and the presence of at least one liver metastasis
             measuring &gt; 1.5 cm in longest diameter in axial dimension on standard anatomic imaging

        Exclusion Criteria (Part B only):

          -  Contra-indication to gadolinium contrast (e.g. chronic renal disease, prior allergic
             reaction) for patient studies

        Exclusion Criteria (Part A [Healthy Volunteers] and Part B):

          -  Contra-indication to MRI (e.g. pacemaker, severe claustrophobia, suspected presence of
             MR-Unsafe surgical implants or shrapnel)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rahul Aggarwal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2015</study_first_submitted>
  <study_first_submitted_qc>March 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2015</study_first_posted>
  <last_update_submitted>April 6, 2018</last_update_submitted>
  <last_update_submitted_qc>April 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Rahul Aggarwal</investigator_full_name>
    <investigator_title>Assistant Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Advanced Solid Tumor</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

